Status | Study |
Withdrawn |
Study Name: Safety Study of ALG- 1001 to Treat Diabetic Macular Edema Condition: Diabetic Macular Edema Date: 2011-11-28 Interventions: Drug: ALG-1001 1.5 mg per 100u |
Completed |
Study Name: Effective Treatment of Posttraumatic and Postoperative Edema Condition: Edema Date: 2011-06-23 Interventions: Other: ice gel pack ice gel pa |
Completed |
Study Name: Glycemic Control and Diabetic Macular Edema Condition: Diabetic Macular Edema Date: 2011-05-19 Interventions: Other: Respond to therapy for diabetic macular edema Correlate HBA1c with visual acuity outcome to thera |
Terminated |
Study Name: Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome Condition: Bone Marrow Edema Date: 2011-05-02 Interventions: Drug: Aclasta 1 x intravenous |
Completed |
Study Name: Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema Condition: Diabetic Macular Edema Date: 2011-04-25 Interventions: Procedure: Intravitreal injection Intravitreal Injections were done under sterile conditions with topica |
Completed |
Study Name: NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Condition: Diabetic Macular Edema Date: 2011-04-06 Interventions: Drug: nepafenac 0.1% drops One |
Completed |
Study Name: MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) Condition: Diabetic Macular Edema Date: 2010-04-23 Interventions: Drug: Ranibizumab 0.05mg Intra |
Completed |
Study Name: Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion Condition: Diabetic Macular Edema Date: 2008-12-26 Interventions: Drug: intravitreal injection of ranibizumab |
Completed |
Study Name: Avastin for Post-Photocoagulation Macular Edema Condition: Macular Edema Date: 2008-12-03 Interventions: Drug: Bevacizumab Intravitreal |
Terminated |
Study Name: Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies Condition: Diabetic Macular Edema Date: 2008-10-22 Interventions: Drug: Methotrexate intravenous 25mg/ml Methotrexate intravenous 25mg/ml delivered once or twice (based o |